It has been reported that B10 cells induced by CD40 mAb10 or CpG19 inhibited arthritis in animal models, suggesting that in vitro induced Bregs could be applied for the treatment of autoimmunity disease. The gene discussed is CD40; the disease is arthritic joint disease.